EMAIL THIS PAGE TO A FRIEND

Human molecular genetics

How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse.


PMID 25935000

Abstract

Splice modulation therapy has shown great clinical promise in Duchenne muscular dystrophy, resulting in the production of dystrophin protein. Despite this, the relationship between restoring dystrophin to established dystrophic muscle and its ability to induce clinically relevant changes in muscle function is poorly understood. In order to robustly evaluate functional improvement, we used in situ protocols in the mdx mouse to measure muscle strength and resistance to eccentric contraction-induced damage. Here, we modelled the treatment of muscle with pre-existing dystrophic pathology using antisense oligonucleotides conjugated to a cell-penetrating peptide. We reveal that 15% homogeneous dystrophin expression is sufficient to protect against eccentric contraction-induced injury. In addition, we demonstrate a >40% increase in specific isometric force following repeated administrations. Strikingly, we show that changes in muscle strength are proportional to dystrophin expression levels. These data define the dystrophin restoration levels required to slow down or prevent disease progression and improve overall muscle function once a dystrophic environment has been established in the mdx mouse model.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA002725
Anti-DMD antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA023885
Anti-DMD antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1408565
Anti-DMD antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
L0663 Anti-Laminin-2 (α-2 Chain) antibody, Rat monoclonal, clone 4H8-2, purified from hybridoma cell culture
N7280
Anti-Nitric Oxide Synthase, Brain (1409-1429) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
N7155 Anti-Nitric Oxide Synthase, Brain (251-270) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB4300426
Anti-NOS1 (Ab-852) antibody produced in rabbit, affinity isolated antibody
SAB2500702
Anti-NOS1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
HPA002131
Anti-VCL antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4503069
Anti-Vinculin antibody produced in rabbit, affinity isolated antibody
SAB1402751
Monoclonal Anti-DMD antibody produced in mouse, clone 3A11, purified immunoglobulin, buffered aqueous solution
D8168
Monoclonal Anti-Dystrophin antibody produced in mouse, clone MANDYS8, ascites fluid
D8043
Monoclonal Anti-Dystrophin antibody produced in mouse, clone MANDRA1, ascites fluid
N2280
Monoclonal Anti-Nitric Oxide Synthase, Brain (1-181) antibody produced in mouse, clone NOS-B1, ascites fluid
SAB1404522
Monoclonal Anti-VCL antibody produced in mouse, clone 3F8-1D4, purified immunoglobulin, buffered aqueous solution
SAB4200080
Monoclonal Anti-Vinculin antibody produced in mouse, clone V284, purified immunoglobulin, buffered aqueous solution